News

HUANOVA Biotechnology has raised tens of millions of RMB (approx. US$5–10 million) in Series A+ funding to advance its self-healing supramolecular biomaterial platform and accelerate clinical and global expansion.

Shanghai-based Angtai Weijing Medical Technology has raised hundreds of millions of RMB in Series B funding to advance its microsurgical robotics portfolio: ophthalmic, universal microsurgery, and endo-gastrointestinal systems.

Rossum Robot has completed the world’s first clinical installation of its R-Universal® Orthopedic Robotic System in Beijing, introducing a data-driven approach to complex fracture reduction.

Suzhou-based ophthalmic device company Microclear Medical has received CE-MDR certification for its SKY Full-Eye Imaging Platform and Ultra-Widefield Laser Fundus Camera, marking an important step in its global expansion.

Beijing-based medtech company New Cloud Medical announced the completion of its B+ financing round led by Dalton Venture, with participation from Taizhou Angel Fund and Qianfeng Investment. The funds will support clinical trials, regulatory approvals, and international expansion.

China’s NMPA has approved Lancet Robotics’ RobPath-Spine® and RobPath® knee navigation systems, marking a key step in the company’s surgical robotics portfolio.

The Global Medical Robotics Conference 2025 in Beijing concluded with the announcement of the annual Global Medical Robotics Awards, recognizing breakthroughs in technology, clinical applications, market impact, global expansion, supply chain, service partnerships, and rehabilitation robotics.

Yuanhua Robotics' KUNWU® surgical robot successfully assisted a knee replacement at 4,000 meters in Tibet, demonstrating sub-millimeter precision in low-oxygen conditions.

China’s magAssist is among 53 nominees for the prestigious 2025 Prix Galien USA “Best Startup” award, highlighting its innovative cardiopulmonary support devices and growing global recognition.

Medical device leader Mindray is pursuing a $1 billion Hong Kong IPO to accelerate its global expansion. With 45% of revenue from international markets, the company is transitioning from equipment exports to integrated healthcare solutions, supported by AI and localized manufacturing.

Between January and June 2025, 74 surgical robots were successfully procured by public hospitals across China. MedRobot presents a sectoral breakdown and insights into market trends, brand performance, and what to expect for the remainder of the year.

Robotrak secures Series C funding to advance its high-precision ophthalmic imaging and laser systems, accelerating global commercialization of its Mona IV and Aglaia 577 platforms.

Lancet Robotics, a leading Chinese surgical robotics company, has raised a multi-million dollar A+ round to accelerate its product innovation and global market expansion.

Boston Scientific launches the Vercise Genus™ DBS System in China, introducing a next-generation, precision-driven solution for Parkinson’s care with real-time visualization and long-lasting therapeutic support.

WEGO Blood Purification raises $150 million in its Shanghai Stock Exchange debut to boost smart manufacturing and R&D in China's dialysis market.

Xellar Biosystems secures strategic investment from XtalPi to pioneer AI-organ chip integration, aiming to revolutionize drug discovery with human-relevant, animal-free testing solutions.

China’s Surgerii Robotics single-port surgical robot achieves NMPA approval for four major specialties, enabling minimally invasive breakthroughs in thoracic and general surgery.

Gaush Meditech Ltd. announced NMPA approval for the Heidelberg ANTERION ophthalmic diagnostic system in China.

Beijing's 2025 policy breakthrough accelerates surgical robot adoption through R&D support, leasing models and DRG reforms, creating new opportunities in China's healthcare market.

Beijing-based Yellwin Medical has completed its Series A++ funding round, raising tens of millions of RMB.

Hangzhou-based Lynmou Medical has successfully closed its Series A funding round, raising tens of millions of RMB.